| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Baicalin is a flavone glycoside, it is a flavonoid. It is the glucuronide of baicalein.
Baicalin is a flavonoid glycoside derived from plants in the genus Scutellaria. It has anxiolytic, anti-cancer and anti-viral properties, and is used in traditional Chinese medicine. Baicalein and baicalin are chemically related, with baicalin being essentially a conjugated (sugar-attached) form of baicalein. This conjugation can modify their biological functions and impacts, making them distinct in certain aspects even though they share several pharmacological properties. baicalin is often hydrolyzed by gut β-glucuronidase to baicalein (aglycone) and then extensively converted to phase-II conjugates (glucuronides/sulfates), which constrains systemic “free” levels after oral dosing. In cancer models, baicalin/baicalein are reported to modulate NF-κB, PI3K/AKT/mTOR, MAPK, and related programs, with downstream effects on cell-cycle arrest, apoptosis, invasion/EMT, and angiogenesis (model-dependent). Baicalein appears to be antioxidant in normal cells (low Cu). In vitro, baicalein can participate in copper-dependent redox cycling under high Cu conditions, leading to ROS generation. Whether this mechanism contributes meaningfully in vivo remains model-dependent. (higher Cu levels) (May applies to other plant polyphenols as well: Ex apigenin, luteolin, EGCG, and resveratrol). Pathways: Apoptosis Pathways (Intrinsic/Mitochondrial): NF-κB Inhibition : PI3K/Akt/mTOR Signaling Pathway downregulate : MAPK/ERK and JNK Signaling Pathways: STAT3 Signaling: (inhibit) Wnt/β-Catenin Signaling Pathway: (suppress) Other Pathways and Effects: • Cell Cycle Arrests (commonly G0/G1 or G2/M) • Anti-angiogenic Effects: By inhibiting VEGF • Modulation of Oxidative Stress: Balancing reactive oxygen species (ROS) levels in cancer cells can also contribute to its antitumor effects. • In normal cells or under conditions of oxidative stress, baicalin has been shown to act as an antioxidant. • In cancer cells, baicalin may increase ROS levels, triggering apoptosis. Lower doses of baicalin might favor antioxidant responses, whereas higher concentrations could lead to ROS accumulation in cancer cells. Redox effects are concentration- and context-dependent; antioxidant behavior predominates in non-tumor oxidative stress models, whereas ROS increases have been reported in some tumor systems at higher concentrations. • If copper levels are elevated in a cancer cell, the additional ROS generated via copper-mediated reactions may synergize with baicalin’s pro-oxidant effects (if observed at higher doses) to exceed the threshold for cancer cell survival. • Conversely, in normal cells with tightly regulated copper levels, baicalin’s antioxidant properties may help in quenching excess ROS or maintaining redox balance. -IC50 in cancer cell lines: Approximately 50–200 µM (with some variability depending on the cell type). • IC50 in normal cell lines: Generally higher, often exceeding 200 µM, though values will vary with experimental conditions. Many in-vitro IC50 values exceed achievable systemic concentrations after oral dosing without advanced formulation. Low oral bioavailability: classic rat PK reports very low absolute BA bioavailability and evidence of enterohepatic cycling
Time-Scale Flag (TSF): P / R / G
|
| Source: |
| Type: |
| Lipid deposition refers to the process by which lipids (fats) accumulate in tissues. Key Markers Implicated in Lipid Deposition with Prognostic Relevance Fatty Acid Synthase (FASN):key enzyme in de novo lipogenesis, catalyzing the synthesis of palmitate. -Frequently overexpressed in cancers, associated with aggressive tumor behavior, resistance to therapy, and poorer overall survival. SREBP-1: A transcription factor that upregulates lipogenic genes (including FASN, ACC, and SCD1). -Overactive in various cancers, correlates with enhanced lipogenesis, increased proliferation, and worse prognosis. ACC:Catalyzes the conversion of acetyl-CoA to malonyl-CoA, a crucial step in fatty acid synthesis. -Overactivity may contribute to increased lipid deposition in tumors, promoting growth and associated with poor outcomes. SCD1: Catalyzes the desaturation of saturated fatty acids to monounsaturated fatty acids, important for membrane fluidity and signaling. -Upregulated in cancers, linked to tumor progression, resistance to apoptosis, and a poorer prognosis. CD36: A fatty acid translocase that facilitates the uptake of long-chain fatty acids and is involved in lipid storage. -Overexpression in various cancer, associated with metastatic potential and worse clinical outcomes. FABPs, (FABP4 and FABP5): Intracellular lipid chaperones that help transport fatty acids and other lipids within cells. -Typically Increased expression in cancers, may correlate with increased lipid uptake/storage, contributing to tumor aggressiveness and poorer survival in some cancer types. Lipid Droplet–Associated Proteins (Perilipins PLIN2 and PLIN3) -Involved in the formation and regulation of lipid droplets, which serve as intracellular lipid storage organelles. -Increased lipid droplet accumulation has been linked to chemotherapy resistance and a worse prognosis in certain cancers. Tumor cells exploit lipid deposition to: -Buffer oxidative stress -Supply membranes for rapid proliferation -Survive nutrient-poor or hypoxic environments |
| 2389- | BA, | Baicalin alleviates lipid accumulation in adipocytes via inducing metabolic reprogramming and targeting Adenosine A1 receptor |
| - | in-vitro, | Obesity, | 3T3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:39 Target#:1147 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid